Genomic Signature Of Colon Cancer May Individualize Treatment

Courtesy ScienceDaily  Tue, 12/02/2008 - 17:30

Researchers have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.


 

More related items

Intense Chemotherapy Wards Off Recurrence In Half Of...
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as front-line treatment remain in remission seven years later, researchers have...

Common Vitamin And Other Micronutrient Supplements...
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a new study.

Ovarian Cancer Stem Cells Identified, Characterized
Researchers have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to...

HP 50g Graphing Calculator (F2229AA#ABA)
If you're a math, science, or engineering professional?or a serious college student?don't leave home without it! HP's most powerful new graphing calculator. The 50G supplies you with...

Kitchen Mysteries: Revealing the Science of Cooking...
An international celebrity and founder of molecular gastronomy, or the scientific investigation of culinary practice, Herv& eacute; This is known for his ground-breaking research into the...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com